Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 14.81% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 37.07%. Over the past 30 days, the price of CPRX has fallen by 9.36%. And in the last five days, it has surged by 4.77%.
In terms of market performance, Catalyst Pharmaceuticals Inc had a somewhat regular. The highest value for the stock in the past year was $24.27 on 11/08/24, while the lowest value was $13.12 on 02/08/24.
52-week price history of CPRX Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Catalyst Pharmaceuticals Inc’s current trading price is -1.28% away from its 52-week high, while its distance from the 52-week low is 82.68%. The stock’s price range for this period has been between $13.12 and $24.27. The Healthcare sector company’s shares saw a trading volume of about 1.13 million for the day, which was higher than the average daily volume of 1.13 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Catalyst Pharmaceuticals Inc (CPRX) has experienced a quarterly rise of 11.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.86B and boasts a workforce of 167 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.38, with a change in price of +4.05. Similarly, Catalyst Pharmaceuticals Inc recorded 1,036,780 in trading volume during the last 100 days, posting a change of +20.34%.
CPRX’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CPRX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CPRX Stock Stochastic Average
As of today, the raw stochastic average of Catalyst Pharmaceuticals Inc over the past 50 days is 94.50%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 94.50%. Additionally, the Stochastic %K and %D values for the company were 81.26% and 75.08%, respectively, over the past 20 days.
